Patient Safety
Improving patient outcomes to ensure the most benefit
At Bristol Myers Squibb, our patients are at the center of everything we do. The mission of Patient Safety is to improve patient outcomes and ensure that our patients get the most benefit from our medications. Our commitment is to help our patients treat serious diseases by providing the best possible care and information about our medicines. We do our best to support our patients at every step, from the early stages of drug development to well after the medicine is available to patients. Safety and well-being of our patients are our top priorities. We are determined, vigilant, and proactive to support our patients.
BMS’ Patient Safety organization works globally to monitor the safety of all our medicines. Any adverse event (AE) that might be linked to a BMS product is thoroughly evaluated in the context of all available data. We additionally collaborate with health authorities from around the world to help address inquiries and update product labeling as needed. The importance of patient safety can be found throughout the company. BMS employees and contractors who become aware of any potential adverse events are responsible for reporting to Patient Safety. Our staff receives training annually on what an adverse event is, how to identify one and the proper procedures for reporting.
Need to report an adverse event?
Patient safety resources
Building a better future
We lead with integrity, transparency and a commitment to advancing health equity. Our science-led approach drives meaningful impact and ensures accountability to those we serve.
Our approach
Advancing patient health around the world
Advancing patient health around the world by ensuring patients have equitable access to innovative medicines regardless of location or ability to pay.Expanding the boundaries of science
Expanding the boundaries of science by addressing unmet patient needs while ensuring a more inclusive and sustainable future for clinical research.Fostering a high-performing global workforce
Fostering a high-performing global workforce by ensuring that our people are at their best so that we can optimally deliver for our patients.Sustaining our planet and improving health
Minimize impacts of our operations to help ensure continued access to our medications for patients.Patient safety resources
Pharmacovigilance & adverse events
Pharmacovigilance:
“pharmaco” = medicine + “vigilance” = paying attention
The World Health Organization (WHO) defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. It involves keeping track of any side effects or adverse reactions that people might experience and taking action to ensure that the medicines remain safe for everyone to use. Expanding upon that vision, the WHO citing aims of improvements in PV methodologies and more effective communication to the public. We embrace those challenges.
Adverse Event:
An adverse event is any unexpected or harmful reaction that occurs when someone is using a medication. This can include side effects, allergic reactions, or any other negative health issues that happen while taking the drug, even if it's not clear that the medication caused the problem. Please use www.globalbmsmedinfo.com to report if you suspect you are experiencing an adverse event with one of our medicines.
Risk evaluation and mitigation strategies (REMS)
Learn more about our commitment to developing the most effective risk evaluation and mitigation strategies (REMS) for our medicines